Shelley B. Thunen
Director · AEON Biopharma, Inc.
- 2024
- Jun 22, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Shelley B. Thunen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shawn Olsson - $261K in LENZ purchases and sales in the last 12 months
- Evert B. Schimmelpennink - $251K in LENZ purchases and sales in the last 12 months
- Timothy P. Lynch - $243K in AEON purchases and sales in the last 12 months
- James W. McCollum - $239K in LENZ purchases and sales in the last 12 months
- Daniel R. Chevallard - $114K in LENZ purchases and sales in the last 12 months
- Mark Wilterding - $54K in RXST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Shelley B. Thunen?
Shelley B. Thunen is a corporate insider, tracked as Director of AEON Biopharma, Inc. (AEON). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Shelley B. Thunen last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 6 filings going back to 2024.
Has Shelley B. Thunen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($727K) across all tracked filings.
